Adaptive Licensing – Maximising Value
Adaptive licensing is currently being promoted as a means for earlier patient access to novel drugs. However, there is a high level of uncertainty regarding the current regulatory feasibility of...
View ArticleThinking Around the Box – Protecting Your Technical Contribution from the start
A patent is a contract between the inventor and the State. Jon Gowshall at Forresters provides an overview on the inventor that agrees to make public their technical contribution to their chosen...
View ArticleEU to Tighten Medical Device Rules
Organisations that deal with medical equipment face stricter European regulation in wake of the serious issues with the Poly Implant Prosthèse (PIP) and hip implants. Andrew Catton at Miller Insurance...
View ArticleAll Eyes on Austria – Vienna Host of the BIO-Europe Conference for a Second...
Sonja Polan at Life Science Austria explains how the Austrian biotechnology industry is a true success story, as can be seen from the record number, 116, of innovative Austrian biotechnology companies...
View Article